Concizumab may be effective prophylaxis for hemophilia A or B with inhibitors

Patients with hemophilia A or B with inhibitors have a lower annualized bleeding rate with concizumab than with no prophylaxis, according to a phase 3 study published online Aug. 31 in the New England Journal of Medicine…
Read More

What's Hot

‘Revive with exports’: Japanese associations gearing up for functional foods export opportunities

Jiahui’s First CAR-T Therapy Patient Completes Treatment

Study reveals irritable bowel syndrome as a long COVID symptom

Concizumab may be effective prophylaxis for hemophilia A or B with inhibitors

Study reveals irritable bowel syndrome as a long COVID symptom

This long COVID survivor gets emotional about her ‘blessing’

Revised Figures Show UK Economy Recovered Faster Post-COVID Than Previously Estimated

The Wheel of Time Season 3: Everything We Know

‘Revive with exports’: Japanese associations gearing up for functional foods export opportunities

Jiahui’s First CAR-T Therapy Patient Completes Treatment

Study reveals irritable bowel syndrome as a long COVID symptom

This long COVID survivor gets emotional about her ‘blessing’

Shot through the art: How COVID policy jeopardised Australian culture

Covid Vaccine: Should You Pay Out of Pocket for Your Shot?

Sophia Loren After Leg-Fracture Surgery: ‘Thanks For All The Affection, I’m Better,’ Just Need Rest

Children’s spinal surgery review finds no failure of metalwork

Jennifer Lawrence’s Face at Dior Show Sparks Plastic Surgery Rumors

Lucintel Forecasts Global Epilepsy Monitoring Device Market to Reach $0.7 billion by 2030

What's Hot

Concizumab may be effective prophylaxis for hemophilia A or B with inhibitors

Related Posts